News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,181 Results
Type
Article (38927)
Company Profile (275)
Press Release (642979)
Section
Business (203791)
Career Advice (1983)
Deals (35354)
Drug Delivery (83)
Drug Development (80755)
Employer Resources (168)
FDA (16079)
Job Trends (14792)
News (344392)
Policy (32427)
Tag
Academia (2530)
Alliances (49021)
Alzheimer's disease (1188)
Approvals (16000)
Artificial intelligence (110)
Bankruptcy (352)
Best Places to Work (11428)
Biotechnology (195)
Breast cancer (94)
Cancer (830)
Career advice (1653)
Cell therapy (188)
Clinical research (63756)
Collaboration (290)
Compensation (155)
COVID-19 (2515)
Cystic fibrosis (78)
Data (755)
Diabetes (121)
Diagnostics (6068)
Drug pricing (74)
Earnings (83894)
Employer resources (145)
Events (108547)
Executive appointments (225)
FDA (16475)
Funding (258)
Gene therapy (141)
GLP-1 (548)
Government (4313)
Healthcare (18644)
Infectious disease (2580)
Inflammatory bowel disease (98)
Interviews (306)
IPO (16246)
Job creations (3622)
Job search strategy (1414)
Layoffs (405)
Legal (7847)
Lung cancer (146)
Manufacturing (139)
Medical device (13119)
Medtech (13124)
Mergers & acquisitions (19085)
Metabolic disorders (335)
Neuroscience (1414)
NextGen Class of 2024 (6488)
Non-profit (4461)
Northern California (1097)
Obesity (202)
Opinion (175)
Patents (89)
People (56064)
Phase I (19768)
Phase II (28070)
Phase III (20971)
Pipeline (187)
Postmarket research (2553)
Preclinical (8413)
Radiopharmaceuticals (234)
Rare diseases (174)
Real estate (5887)
Regulatory (21404)
Research institute (2306)
Resumes & cover letters (348)
Southern California (1014)
Startups (3560)
United States (10799)
Vaccines (522)
Weight loss (151)
Date
Today (142)
Last 7 days (639)
Last 30 days (2710)
Last 365 days (36091)
2024 (29285)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (183)
Asia (36952)
Australia (6023)
California (2496)
Canada (1126)
China (191)
Colorado (108)
Connecticut (107)
Europe (79093)
Florida (358)
Georgia (88)
Illinois (295)
Indiana (167)
Kansas (95)
Maryland (481)
Massachusetts (2025)
Michigan (140)
Minnesota (242)
New Jersey (754)
New York (764)
North Carolina (641)
Northern California (1097)
Ohio (120)
Pennsylvania (718)
South America (1091)
Southern California (1014)
Texas (342)
Utah (71)
Washington State (293)
682,181 Results for "cryoport inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cryoport Reports First Quarter 2024 Financial Results
Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences, today announced financial results for the three months ended March 31 (Q1), 2024.
May 7, 2024
·
19 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Business
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
Cryoport, Inc. today announced that the Company will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after U.S. markets close.
April 30, 2024
·
5 min read
Business
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global leader in supply chain solutions for cell & gene therapies, today announced financial results for the fourth quarter (Q4) and year (FY) ended December 31, 2023.
March 12, 2024
·
22 min read
Business
Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Cryoport, Inc. today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2023 on Tuesday, March 12, 2024 after U.S. markets close.
February 27, 2024
·
4 min read
Business
Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
Cryoport, Inc. today announced that the Company will report financial results for the third quarter ended September 30, 2023 on Wednesday, November 8, 2023 after U.S. markets close.
October 25, 2023
·
4 min read
Business
Cryoport Reports Second Quarter 2023 Financial Results
Cryoport, Inc. announced financial results for the second quarter and first half of 2023.
August 9, 2023
·
20 min read
BioMidwest
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
Cryoport, Inc. announced that the Company has signed a new three-year supply chain solutions agreement with Monash IVF Group Limited, a leading provider of assisted reproductive services, as well as specialist women’s imaging and diagnostic services in Australia and Southeast Asia.
October 12, 2023
·
5 min read
Business
Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
Cryoport, Inc. and the Cell and Gene Therapy Catapult (“CGT Catapult”), an independent innovation and technology organisation specializing in the advancement of cell and gene therapies, today announced the organisations have entered into a new strategic partnership to support the advancement of cell and gene therapies.
October 10, 2023
·
5 min read
Business
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023
Cryoport, Inc. today announced that the Company will report financial results for the second quarter ended June 30, 2023 on Wednesday, August 9, 2023 after U.S. markets close.
August 2, 2023
·
4 min read
1 of 68,219
Next
